The escalating pressure on providers to dramatically change how they organize and deliver care will continue in the years ahead, according to a report from Modern Healthcare. Bottom line-oriented employers, cash-strapped families, and tax-starved governments will insist on it.

The FDA has approved Ingrezza capsules (valbenazine, Neurocrine Biosciences, Inc.) to treat adults with tardive dyskinesia. This is the first and only drug approved by the FDA for this condition. 

Historically, the U.S. health care system has not made it easy for people to find out how much their care will cost them out of pocket. Public Agenda, with support from the Robert Wood Johnson Foundation and the New York State Health Foundation, recently conducted a survey to explore how Americans are trying to find and use this information.

Middle-aged individuals with risk factors for heart attacks and stroke are also more likely to develop changes in the brain that can precede the development of Alzheimer's disease, according to a study led by the Johns Hopkins University School of Medicine.

People living in areas that restrict trans fats in foods had fewer hospitalizations for heart attack and stroke compared with residents in areas without restrictions, according to a study led by a Yale researcher.

Regulators and medical device-makers are bracing for an expected barrage of hacking attacks, according to a report from The Hill. High-profile attacks have hit hospitals and health insurers in recent years, and now attention is turning to a new vulnerability: medical devices, such as pacemakers and insulin pumps.

The Trump administration says that it is willing to continue paying subsidies to health insurance companies under the Patient Protection and Affordable Care Act (PPACA), according to an article in The New York Times.

Lawmakers from both parties are calling on Congress to establish a dedicated funding source to fight infectious-disease outbreaks, according to an article posted on the Morning Consult website.

Kimberly-Clark and its spinoff medical-technology firm Halyard Health have been hit with $454 million in compensatory and punitive damages after a federal jury in Los Angeles found that the companies misled California buyers about the impermeability of their MicroCool surgical gowns, according to an Associated Press report.

Researchers at the University of Nebraska–Lincoln have demonstrated that nesting specialized nanoparticles inside microparticles could protect engineered genes or virus-derived DNA against the rigors of the stomach and ensure safe passage to the intestine.

Talk to your doctor, patients are advised. The U.S. Preventive Services Task Force (USPSTF) has loosened its guidance on whether men should take the prostate-specific antigen (PSA) blood test.

Last year, the Centers for Medicare and Medicaid Services (CMS) announced applications for the Accountable Health Communities (AHC) model.

Johnson & Johnson, Novartis, and Roche boast the strongest pipelines among the industry’s top players, according to a report from The Motley Fool. Here’s what sets these drug makers apart from their peers.

Johnson & Johnson

In February, after speaking with top pharma executives at the White House, President Trump described the FDA’s approval process as “slow and burdensome” and said he would back measures to get promising medications to patients faster. His nominee for FDA commissioner, Scott Gottlieb, has expressed a similar viewpoint.

A new study published by JAMA Neurology examines hospitalization rates for acute ischemic stroke in “younger” adults (18 to 64 years of age) by stroke type and patient age, sex, and race/ethnicity, along with associated risk factors.